Toxic air fuels sale of respiratory drugs, segment grows 14.7% in October

Edit
Cipla, a market leader in respiratory segment, advances to the second position from third, replacing Abbott in October


Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)